TD Cowen lowered the firm’s price target on Agilon Health to $12 from $18 and keeps an Outperform rating on the shares. The firm said as guidance and EBITDa collpases, they contemplate the cmpany’s strategic value as the current valuation assigns little strategic value to the enterprise.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AGL: